arrow
V

Vladimír Džavík

university health network toronto
H指数:54
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial

ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后无复流: 整个试验的血管造影核心实验室分析

2023-08-019
PRE
Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index
2022-10-015
OAAI
Double-blind, placebo-controlled evaluation of biorest liposomal alendronate in diabetic patients undergoing PCI: The BLADE-PCI trial
2022-07-012
PRE
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI A Prespecified TWILIGHT Substudy
2022-02-0110
OAAI
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS

非ST段抬高急性冠脉综合征患者经皮冠状动脉介入治疗后单用替格瑞洛与替格瑞洛联合阿司匹林的比较: TWILIGHT-ACS

2020-10-20116
OAAI
Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial

全部试验中接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者氯吡格雷、普拉格雷和替格瑞洛的结局

2019-10-0124
PREAI
Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration
2018-04-2128
OAAI
The Presence of a CTO in a Non-Infarct-Related Artery During a STEMI Treated With Contemporary Primary PCI Is Associated With Increased Rates of Early and Late Cardiovascular Morbidity and Mortality The CTO-TOTAL Substudy
2018-04-0127
OAAI